Brought to you by 
Series B brings in $16.1mm so far for Akebia Therapeutics
04 Jun 2013
Executive Summary
Akebia Therapeutics Inc. (blood and vascular treatments) has raised $12mm of a potential $19mm through its Series B venture round from 21 undisclosed investors. The company brought in $21mm through its Series A financing.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B brings in $16.1mm so far for Akebia Therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice